[go: up one dir, main page]

ES8101585A1 - Procedimiento de obtencion de un nuevo compuesto antiateros-clerotico - Google Patents

Procedimiento de obtencion de un nuevo compuesto antiateros-clerotico

Info

Publication number
ES8101585A1
ES8101585A1 ES488665A ES488665A ES8101585A1 ES 8101585 A1 ES8101585 A1 ES 8101585A1 ES 488665 A ES488665 A ES 488665A ES 488665 A ES488665 A ES 488665A ES 8101585 A1 ES8101585 A1 ES 8101585A1
Authority
ES
Spain
Prior art keywords
hyperlipoproteinaemia
isobutyrate
para
hypolipaemic
hypocholesterolaemic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES488665A
Other languages
English (en)
Other versions
ES488665A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sociedad Espanola de Especialidades Farmaco Terapeuticas SA
Original Assignee
Sociedad Espanola de Especialidades Farmaco Terapeuticas SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sociedad Espanola de Especialidades Farmaco Terapeuticas SA filed Critical Sociedad Espanola de Especialidades Farmaco Terapeuticas SA
Priority to ES488665A priority Critical patent/ES8101585A1/es
Priority to FR8017235A priority patent/FR2476095A1/fr
Priority to BE2/58700A priority patent/BE884722A/fr
Publication of ES488665A0 publication Critical patent/ES488665A0/es
Publication of ES8101585A1 publication Critical patent/ES8101585A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE 2-P-CLOROFENOXIISOBUTIRATO-1,3-DINICOTINATO DE TRIHIDROXIPROPANO. CONSISTE EN HACER REACCIONAR EN REACCION DE ESTERIFICACION, DEL ACIDO P-CLOROFENOXIISOBUTIRICO CON EL 1,3-DIHALOGENO-2-PROPANOL, EN UN MEDIO DISOLVENTE INERTE (TAL COMO BENZOL, TOLUOL O XILOL). EN LA REACCION SE EMPLEAN CATALIZADORES Y MEDIOS DE CAPTACION DEL AGUA PRODUCIDA EN LA REACCION. SE OBTIENE EL COMPUESTO 2,P-CLORO-FENOXIISOBUTIRATO DE 1''.3''-DIHALOGENO-ISOPROPILO, QUE SE HACE REACCIOANR CON LA SAL NICOTINICA DE UN METAL ALCALINO. SE OBTIENE UN COMPUESTO DE FORMULA ESTRUCTURAL (I). *FORMULA* TRATAMIENTO DE HIPERLIPEMIAS E HIPERCOLESTEROLEMIAS PRIMARIA O SECUNDARIA. PREVENCION DE ARTERIOSCLEROSIS.
ES488665A 1980-02-15 1980-02-15 Procedimiento de obtencion de un nuevo compuesto antiateros-clerotico Expired ES8101585A1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ES488665A ES8101585A1 (es) 1980-02-15 1980-02-15 Procedimiento de obtencion de un nuevo compuesto antiateros-clerotico
FR8017235A FR2476095A1 (en) 1980-02-15 1980-08-01 Glyceryl 2-para-chloro:phenoxy-isobutyrate-1,3-di:nicotinate - hypolipaemic and hypocholesterolaemic used to treat atherosclerosis, hyperlipoproteinaemia and high tri:glyceride plasma levels
BE2/58700A BE884722A (fr) 1980-02-15 1980-08-12 Nouvel ester mixte symetrique de 1,2,3-trihydroxypropane, son procede d'obtention et ses applications therapeutiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES488665A ES8101585A1 (es) 1980-02-15 1980-02-15 Procedimiento de obtencion de un nuevo compuesto antiateros-clerotico

Publications (2)

Publication Number Publication Date
ES488665A0 ES488665A0 (es) 1980-12-16
ES8101585A1 true ES8101585A1 (es) 1980-12-16

Family

ID=8479833

Family Applications (1)

Application Number Title Priority Date Filing Date
ES488665A Expired ES8101585A1 (es) 1980-02-15 1980-02-15 Procedimiento de obtencion de un nuevo compuesto antiateros-clerotico

Country Status (3)

Country Link
BE (1) BE884722A (es)
ES (1) ES8101585A1 (es)
FR (1) FR2476095A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692262B1 (fr) * 1992-06-10 1994-08-05 Adir Nouveaux nicotinates de diacylglycerols, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
SI1413331T1 (sl) 2001-01-26 2008-02-29 Schering Corp Kombinacije fenofibrata peroksisomskega proliferator aktivirajocega receptorja (PPAR) z ezetimib zaviralcem absorpcije sterola za vaskularne indikacije
RS50406B (sr) 2001-01-26 2009-12-31 Schering Corporation, Upotreba supstituisanih jedinjenja azetidinona za lečenje sitosterolemije
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
MXPA04002573A (es) 2001-09-21 2004-06-18 Schering Corp Tratamiento de xantoma con derivados de azetidinona como inhibidores de la absorcion de esterol.
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
EP1562582A1 (en) 2002-11-06 2005-08-17 Schering Corporation Cholesterol absorption inhibitors for the treatment of demyelination
ES2311806T3 (es) 2003-03-07 2009-02-16 Schering Corporation Compuesto de azetidinona sustituidos, fornulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
JP4589919B2 (ja) 2003-03-07 2010-12-01 シェーリング コーポレイション 高コレステロール血症の処置のための、置換アゼチジノン化合物、これらの処方物および使用
US7192944B2 (en) 2003-03-07 2007-03-20 Schering Corp. Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
TW200901959A (en) 2007-03-09 2009-01-16 Indigene Pharmaceuticals Inc Combination of metformin R-(+) lipoate and antihyperlipidemic agents for the treatment of diabetic hyperglycemia and diabetic complications
EP3253382B1 (en) 2015-02-06 2021-11-17 Intercept Pharmaceuticals, Inc. Pharmaceutical compositions for combination therapy
CA3142358A1 (en) 2019-05-30 2020-12-03 Intercept Pharmaceuticals, Inc. Pharmaceutical compositions comprising a fxr agonist and a fibrate for use in the treatment of cholestatic liver disease

Also Published As

Publication number Publication date
ES488665A0 (es) 1980-12-16
FR2476095A1 (en) 1981-08-21
BE884722A (fr) 1980-12-01
FR2476095B1 (es) 1984-03-09

Similar Documents

Publication Publication Date Title
ES8101585A1 (es) Procedimiento de obtencion de un nuevo compuesto antiateros-clerotico
AU593317B2 (en) Pharmaceutical compositions
NO912151L (no) Essensiell-fettsyre-behandling.
FR2407921A1 (fr) Nouveaux 7-oxa-bicycloheptanes et -bicycloheptenes, utiles notamment comme agents cardiovasculaires, et leur procede de preparation
TNSN90021A1 (fr) Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales
ZA831704B (en) Pharmaceutically active copolymers,process for their preparation and pharmaceutical compositions containing them
ATE1734T1 (de) Schmerzstillende tablette und verfahren zu deren herstellung.
DE68926115D1 (de) Verfahren zur behandlung von akne
ES8503643A1 (es) Un procedimiento para la preparacion de compuestos de bis (carboxamida)
FR2448899A1 (fr) Utilisation therapeutique de l'acide 6,7-dichloro-3,4-dihydro-3-oxo-2-quinoxalinecarboxylique et de ses esters
ID21038A (id) Tablet yang mengandung resin penukar anion
ES449939A1 (es) Procedimiento para preparar sulfuro de difenilo sustituido.
RU93010275A (ru) Глазные капли "кератоник"
JPS552601A (en) Anti-tumor agent for non-injection use
KR940013503A (ko) 동맥경화증의 예방 또는 치료용 약제학적 조성물
HUP9800964A2 (hu) O- és S-tartalmú 6 tagú benzo-kondenzált heterociklusos vegyületek, eljárás ezek előállítására, és ezeket tartalmazó gyógyászati készítmények
ES8500898A1 (es) Procedimiento para preparar esteres de acidos benzosulfonicos substituidos.
BE900607A (fr) Agents prophylactiques et medicaments anti-adhesifs contenant un derive de benzylamine ayant une action secretolytique.
IE810901L (en) Naphthotriazoles.
DE3369327D1 (en) Pharmaceutical compounds, preparation, use and intermediates therefor and their preparation
ES8201521A1 (es) Un procedimiento para la preparacion de nuevos derivados de acido propanoico
WO1987003590A1 (fr) Medicament pour le traitement des maladies du foie
TNSN94110A1 (fr) Procede de preparation de compositions orales contenant des quinolones
FR2424027A1 (fr) Nouveau medicament, notamment sedatif et inducteur de sommeil et compositions pharmaceutiques la renfermant
JPS5498339A (en) Carcinostatic agent

Legal Events

Date Code Title Description
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 19991217